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A commentary on
A 12-year population-based study of freezing of gait in Parkinson’s disease
by Forsaa, E. B., Larsen, J. P., Wentzel-Larsen, T., and Alves, G. (2015). Parkinsonism Relat. Disord.
21, 254–258. doi: 10.1016/j.parkreldis.2014.12.020
A recent study by Forsaa et al. (2015) details the prospective assessments of a population-based
Parkinson’s disease (PD) cohort, investigating the long-term progression and associated risk factors
of freezing of gait (FOG). Building on previous work examining the progression of psychosis in
PD (Forsaa et al., 2010), the authors followed a cohort of 232 PD patients, assessing both motor
and non-motor disease features including FOG, severity of parkinsonism, motor complications,
psychotic symptoms, and cognitive impairment at 4 and 8 years, and annually thereafter.
In this study, Forsaa et al. (2015) utilized a prospective longitudinal research design, allowing
for investigating and predicting symptom progression. This predictive capability is of importance
to intervention and therapy, as FOG is associated with reduced quality of life (Moore et al., 2007;
Walton et al., 2015), increased risk of falls and subsequent medical complications (Bloem et al.,
2004), caregiver-burden (Schrag et al., 2006), and self-initiated social isolation (Bloem et al., 2004).
Forsaa et al. (2015) suggest that many PD patients may develop FOG during their disease
course. This finding aids in remediating a discrepancy in the “freezing” literature, in relation to
the highly variable prevalence rates of FOG in PD patients, with past research reporting variable
rates between 31 and 87% (Hely et al., 2005; Macht et al., 2007; López et al., 2010; Auyeung et al.,
2012; Perez-Lloret et al., 2014). Forsaa et al. (2015) report a FOG point prevalence rate of 25% at
the commencement of the study, 75% at the 8-year follow-up, and 63% at the end of the study. This
variability in the literature may result from previous overreliance on cross-sectional research, as
well as dropout rates stemming from non-PD related comorbidities and increased mortality in PD
patients displaying FOG.
As shown by Forsaa et al’s (2015) long-term prospective follow-up design, repeated assessments
of disease features and the use of robust statistical analyses, including logistic regressionmodels and
generalized estimating equations, the risk factors and concomitant features of FOG were explored
in isolation from one another. The analyses revealed a significant relationship between motor
fluctuations and FOG, as non-“freezers” presenting with motor fluctuations at the commencement
of the study had more than three times the likelihood of developing FOG during the 12-year
follow-up period, as compared with patients without motor fluctuations at baseline. Interestingly,
dyskinesias were associated with a statistically non-significant (but still greater than 60%) reduced
risk of incidence of FOG during follow-up, a finding that needs further confirmation, as suggested
by Forsaa et al. (2015).
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Currently, complete understanding of the pathophysiology of
dyskinesias and motor fluctuations remains elusive. However,
both appear to be associated with the degree of dopamine
depletion and the use of levodopa (L-Dopa) (Linazasoro, 2007;
Calabresi et al., 2008; Antonini et al., 2010), with approximately
50–80% of PD patients who receive L-Dopa for more than 5–
10 years developing such complications (Marsden and Parkes,
1977; Rajput et al., 2002). There is mounting evidence that
such motor complications might be somewhat related to the
short-half life of the drug, as well as its potential to induce
pulsatile stimulation of dopamine receptors. Further, treatment
strategies utilizing continuous stimulation of dopamine receptors
often result in reduced motor complications (Olanow et al.,
2004; Antonini et al., 2010). While more research needs to be
conducted, Forsaa et al’s (2015) results of differential risk for FOG
between dyskinesias and motor fluctuation suggest that the two
may affect the basal ganglia and other brain areas differently.
The pathophysiology of FOG has been suggested to
involve both dopaminergic and nondopaminergic networks
in cortical, subcortical and brainstem regions (Shine et al.,
2011), as evidenced by experimental and neuroimaging
studies investigating the triggering of freezing episodes by
visual, cognitive, and attentional tasks, as well as other
environmental cues (Yogev-Seligmann et al., 2008; Almeida
and Lebold, 2010; Cowie et al., 2010, 2012; Snijders et al.,
2010; Matar et al., 2014; Plotnik et al., 2014). In support
of the above, Forsaa et al. (2015) found that the severity
of postural instability and gait disturbances (PIGD), as
well as psychotic symptoms, each of which are thought to
relate to extrastriatal pathology (Williams-Gray et al., 2006;
Grimbergen et al., 2009), were independently associated
with the occurrence of FOG during the 12-year study
period.
Forsaa et al. identified several limitations to their research.
First, the lack of neuropsychological data collected on subjects
might have allowed for attentional dysfunctions and deficits
in executive function to slip through unrecognized. Also, long
intervals between follow-ups during the first eight years were
identified as another limitation, one that was however remedied
from the 8-year mark onward. During the initial 8 years,
136 subjects died, in which important data may have been
missed. Another limitation is the authors’ method of FOG
assessment, which entailed utilizing a single item from the
Unified Parkinson’s Disease Rating Scale (UPDRS). This is
limiting in that it is a fairly crude measure of “freezing,” which
may not allow for identifying of subtler aspects of gait. However,
until recently, more expansive questionnaires detailing in-depth
descriptions of FOG were unavailable (Nieuwboer et al., 2009),
but the utility and sensitivity of the New Freezing of Gait
Questionnaire is still an issue of contention (Shine et al., 2012).
Given the high frequency of FOG in the PD population
and its inherent negative consequences, more research into the
pathophysiology, treatment and prevention of this symptom
is necessary. Forsaa et al. (2015) demonstrate the utility
of a population-based, longitudinal design in understanding
a progressive disease like PD, offering new insights into
potential predictive risk factors for FOG, and adds to the
evidence-based conceptualization of PD not as the classical
“disease of dopamine,” but as a complex, multi-network, multi-
neurotransmitter system disease.
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